A rapid volume of interest-based approach of radiomics analysis of breast MRI for tumor decoding and phenotyping of breast cancer
Recently, radiomics has emerged as a non-invasive, imaging-based tissue characterization method in multiple cancer types. One limitation for robust and reproducible analysis lies in the inter-reader variability of the tumor annotations, which can potentially cause differences in the extracted featur...
Saved in:
| Published in | PloS one Vol. 15; no. 6; p. e0234871 |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Public Library of Science
26.06.2020
Public Library of Science (PLoS) |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1932-6203 1932-6203 |
| DOI | 10.1371/journal.pone.0234871 |
Cover
| Abstract | Recently, radiomics has emerged as a non-invasive, imaging-based tissue characterization method in multiple cancer types. One limitation for robust and reproducible analysis lies in the inter-reader variability of the tumor annotations, which can potentially cause differences in the extracted feature sets and results. In this study, the diagnostic potential of a rapid and clinically feasible VOI (Volume of Interest)-based approach to radiomics is investigated to assess MR-derived parameters for predicting molecular subtype, hormonal receptor status, Ki67- and HER2-Expression, metastasis of lymph nodes and lymph vessel involvement as well as grading in patients with breast cancer.
A total of 98 treatment-naïve patients (mean 59.7 years, range 28.0-89.4) with BI-RADS 5 and 6 lesions who underwent a dedicated breast MRI prior to therapy were retrospectively included in this study. The imaging protocol comprised dynamic contrast-enhanced T1-weighted imaging and T2-weighted imaging. Tumor annotations were obtained by drawing VOIs around the primary tumor lesions followed by thresholding. From each segmentation, 13.118 quantitative imaging features were extracted and analyzed with machine learning methods. Validation was performed by 5-fold cross-validation with 25 repeats.
Predictions for molecular subtypes obtained AUCs of 0.75 (HER2-enriched), 0.73 (triple-negative), 0.65 (luminal A) and 0.69 (luminal B). Differentiating subtypes from one another was highest for HER2-enriched vs triple-negative (AUC 0.97), followed by luminal B vs triple-negative (0.86). Receptor status predictions for Estrogen Receptor (ER), Progesterone Receptor (PR) and Hormone receptor positivity yielded AUCs of 0.67, 0.69 and 0.69, while Ki67 and HER2 Expressions achieved 0.81 and 0.62. Involvement of the lymph vessels could be predicted with an AUC of 0.8, while lymph node metastasis yielded an AUC of 0.71. Models for grading performed similar with an AUC of 0.71 for Elston-Ellis grading and 0.74 for the histological grading.
Our preliminary results of a rapid approach to VOI-based tumor-annotations for radiomics provides comparable results to current publications with the perks of clinical suitability, enabling a comprehensive non-invasive platform for breast tumor decoding and phenotyping. |
|---|---|
| AbstractList | BackgroundRecently, radiomics has emerged as a non-invasive, imaging-based tissue characterization method in multiple cancer types. One limitation for robust and reproducible analysis lies in the inter-reader variability of the tumor annotations, which can potentially cause differences in the extracted feature sets and results. In this study, the diagnostic potential of a rapid and clinically feasible VOI (Volume of Interest)-based approach to radiomics is investigated to assess MR-derived parameters for predicting molecular subtype, hormonal receptor status, Ki67- and HER2-Expression, metastasis of lymph nodes and lymph vessel involvement as well as grading in patients with breast cancer.MethodsA total of 98 treatment-naïve patients (mean 59.7 years, range 28.0-89.4) with BI-RADS 5 and 6 lesions who underwent a dedicated breast MRI prior to therapy were retrospectively included in this study. The imaging protocol comprised dynamic contrast-enhanced T1-weighted imaging and T2-weighted imaging. Tumor annotations were obtained by drawing VOIs around the primary tumor lesions followed by thresholding. From each segmentation, 13.118 quantitative imaging features were extracted and analyzed with machine learning methods. Validation was performed by 5-fold cross-validation with 25 repeats.ResultsPredictions for molecular subtypes obtained AUCs of 0.75 (HER2-enriched), 0.73 (triple-negative), 0.65 (luminal A) and 0.69 (luminal B). Differentiating subtypes from one another was highest for HER2-enriched vs triple-negative (AUC 0.97), followed by luminal B vs triple-negative (0.86). Receptor status predictions for Estrogen Receptor (ER), Progesterone Receptor (PR) and Hormone receptor positivity yielded AUCs of 0.67, 0.69 and 0.69, while Ki67 and HER2 Expressions achieved 0.81 and 0.62. Involvement of the lymph vessels could be predicted with an AUC of 0.8, while lymph node metastasis yielded an AUC of 0.71. Models for grading performed similar with an AUC of 0.71 for Elston-Ellis grading and 0.74 for the histological grading.ConclusionOur preliminary results of a rapid approach to VOI-based tumor-annotations for radiomics provides comparable results to current publications with the perks of clinical suitability, enabling a comprehensive non-invasive platform for breast tumor decoding and phenotyping. Recently, radiomics has emerged as a non-invasive, imaging-based tissue characterization method in multiple cancer types. One limitation for robust and reproducible analysis lies in the inter-reader variability of the tumor annotations, which can potentially cause differences in the extracted feature sets and results. In this study, the diagnostic potential of a rapid and clinically feasible VOI (Volume of Interest)-based approach to radiomics is investigated to assess MR-derived parameters for predicting molecular subtype, hormonal receptor status, Ki67- and HER2-Expression, metastasis of lymph nodes and lymph vessel involvement as well as grading in patients with breast cancer. A total of 98 treatment-naïve patients (mean 59.7 years, range 28.0-89.4) with BI-RADS 5 and 6 lesions who underwent a dedicated breast MRI prior to therapy were retrospectively included in this study. The imaging protocol comprised dynamic contrast-enhanced T1-weighted imaging and T2-weighted imaging. Tumor annotations were obtained by drawing VOIs around the primary tumor lesions followed by thresholding. From each segmentation, 13.118 quantitative imaging features were extracted and analyzed with machine learning methods. Validation was performed by 5-fold cross-validation with 25 repeats. Predictions for molecular subtypes obtained AUCs of 0.75 (HER2-enriched), 0.73 (triple-negative), 0.65 (luminal A) and 0.69 (luminal B). Differentiating subtypes from one another was highest for HER2-enriched vs triple-negative (AUC 0.97), followed by luminal B vs triple-negative (0.86). Receptor status predictions for Estrogen Receptor (ER), Progesterone Receptor (PR) and Hormone receptor positivity yielded AUCs of 0.67, 0.69 and 0.69, while Ki67 and HER2 Expressions achieved 0.81 and 0.62. Involvement of the lymph vessels could be predicted with an AUC of 0.8, while lymph node metastasis yielded an AUC of 0.71. Models for grading performed similar with an AUC of 0.71 for Elston-Ellis grading and 0.74 for the histological grading. Our preliminary results of a rapid approach to VOI-based tumor-annotations for radiomics provides comparable results to current publications with the perks of clinical suitability, enabling a comprehensive non-invasive platform for breast tumor decoding and phenotyping. Background Recently, radiomics has emerged as a non-invasive, imaging-based tissue characterization method in multiple cancer types. One limitation for robust and reproducible analysis lies in the inter-reader variability of the tumor annotations, which can potentially cause differences in the extracted feature sets and results. In this study, the diagnostic potential of a rapid and clinically feasible VOI (Volume of Interest)-based approach to radiomics is investigated to assess MR-derived parameters for predicting molecular subtype, hormonal receptor status, Ki67- and HER2-Expression, metastasis of lymph nodes and lymph vessel involvement as well as grading in patients with breast cancer. Methods A total of 98 treatment-naïve patients (mean 59.7 years, range 28.0–89.4) with BI-RADS 5 and 6 lesions who underwent a dedicated breast MRI prior to therapy were retrospectively included in this study. The imaging protocol comprised dynamic contrast-enhanced T1-weighted imaging and T2-weighted imaging. Tumor annotations were obtained by drawing VOIs around the primary tumor lesions followed by thresholding. From each segmentation, 13.118 quantitative imaging features were extracted and analyzed with machine learning methods. Validation was performed by 5-fold cross-validation with 25 repeats. Results Predictions for molecular subtypes obtained AUCs of 0.75 (HER2-enriched), 0.73 (triple-negative), 0.65 (luminal A) and 0.69 (luminal B). Differentiating subtypes from one another was highest for HER2-enriched vs triple-negative (AUC 0.97), followed by luminal B vs triple-negative (0.86). Receptor status predictions for Estrogen Receptor (ER), Progesterone Receptor (PR) and Hormone receptor positivity yielded AUCs of 0.67, 0.69 and 0.69, while Ki67 and HER2 Expressions achieved 0.81 and 0.62. Involvement of the lymph vessels could be predicted with an AUC of 0.8, while lymph node metastasis yielded an AUC of 0.71. Models for grading performed similar with an AUC of 0.71 for Elston-Ellis grading and 0.74 for the histological grading. Conclusion Our preliminary results of a rapid approach to VOI-based tumor-annotations for radiomics provides comparable results to current publications with the perks of clinical suitability, enabling a comprehensive non-invasive platform for breast tumor decoding and phenotyping. Background Recently, radiomics has emerged as a non-invasive, imaging-based tissue characterization method in multiple cancer types. One limitation for robust and reproducible analysis lies in the inter-reader variability of the tumor annotations, which can potentially cause differences in the extracted feature sets and results. In this study, the diagnostic potential of a rapid and clinically feasible VOI (Volume of Interest)-based approach to radiomics is investigated to assess MR-derived parameters for predicting molecular subtype, hormonal receptor status, Ki67- and HER2-Expression, metastasis of lymph nodes and lymph vessel involvement as well as grading in patients with breast cancer. Methods A total of 98 treatment-naïve patients (mean 59.7 years, range 28.0–89.4) with BI-RADS 5 and 6 lesions who underwent a dedicated breast MRI prior to therapy were retrospectively included in this study. The imaging protocol comprised dynamic contrast-enhanced T1-weighted imaging and T2-weighted imaging. Tumor annotations were obtained by drawing VOIs around the primary tumor lesions followed by thresholding. From each segmentation, 13.118 quantitative imaging features were extracted and analyzed with machine learning methods. Validation was performed by 5-fold cross-validation with 25 repeats. Results Predictions for molecular subtypes obtained AUCs of 0.75 (HER2-enriched), 0.73 (triple-negative), 0.65 (luminal A) and 0.69 (luminal B). Differentiating subtypes from one another was highest for HER2-enriched vs triple-negative (AUC 0.97), followed by luminal B vs triple-negative (0.86). Receptor status predictions for Estrogen Receptor (ER), Progesterone Receptor (PR) and Hormone receptor positivity yielded AUCs of 0.67, 0.69 and 0.69, while Ki67 and HER2 Expressions achieved 0.81 and 0.62. Involvement of the lymph vessels could be predicted with an AUC of 0.8, while lymph node metastasis yielded an AUC of 0.71. Models for grading performed similar with an AUC of 0.71 for Elston-Ellis grading and 0.74 for the histological grading. Conclusion Our preliminary results of a rapid approach to VOI-based tumor-annotations for radiomics provides comparable results to current publications with the perks of clinical suitability, enabling a comprehensive non-invasive platform for breast tumor decoding and phenotyping. Recently, radiomics has emerged as a non-invasive, imaging-based tissue characterization method in multiple cancer types. One limitation for robust and reproducible analysis lies in the inter-reader variability of the tumor annotations, which can potentially cause differences in the extracted feature sets and results. In this study, the diagnostic potential of a rapid and clinically feasible VOI (Volume of Interest)-based approach to radiomics is investigated to assess MR-derived parameters for predicting molecular subtype, hormonal receptor status, Ki67- and HER2-Expression, metastasis of lymph nodes and lymph vessel involvement as well as grading in patients with breast cancer. A total of 98 treatment-naïve patients (mean 59.7 years, range 28.0-89.4) with BI-RADS 5 and 6 lesions who underwent a dedicated breast MRI prior to therapy were retrospectively included in this study. The imaging protocol comprised dynamic contrast-enhanced T1-weighted imaging and T2-weighted imaging. Tumor annotations were obtained by drawing VOIs around the primary tumor lesions followed by thresholding. From each segmentation, 13.118 quantitative imaging features were extracted and analyzed with machine learning methods. Validation was performed by 5-fold cross-validation with 25 repeats. Predictions for molecular subtypes obtained AUCs of 0.75 (HER2-enriched), 0.73 (triple-negative), 0.65 (luminal A) and 0.69 (luminal B). Differentiating subtypes from one another was highest for HER2-enriched vs triple-negative (AUC 0.97), followed by luminal B vs triple-negative (0.86). Receptor status predictions for Estrogen Receptor (ER), Progesterone Receptor (PR) and Hormone receptor positivity yielded AUCs of 0.67, 0.69 and 0.69, while Ki67 and HER2 Expressions achieved 0.81 and 0.62. Involvement of the lymph vessels could be predicted with an AUC of 0.8, while lymph node metastasis yielded an AUC of 0.71. Models for grading performed similar with an AUC of 0.71 for Elston-Ellis grading and 0.74 for the histological grading. Our preliminary results of a rapid approach to VOI-based tumor-annotations for radiomics provides comparable results to current publications with the perks of clinical suitability, enabling a comprehensive non-invasive platform for breast tumor decoding and phenotyping. Recently, radiomics has emerged as a non-invasive, imaging-based tissue characterization method in multiple cancer types. One limitation for robust and reproducible analysis lies in the inter-reader variability of the tumor annotations, which can potentially cause differences in the extracted feature sets and results. In this study, the diagnostic potential of a rapid and clinically feasible VOI (Volume of Interest)-based approach to radiomics is investigated to assess MR-derived parameters for predicting molecular subtype, hormonal receptor status, Ki67- and HER2-Expression, metastasis of lymph nodes and lymph vessel involvement as well as grading in patients with breast cancer.BACKGROUNDRecently, radiomics has emerged as a non-invasive, imaging-based tissue characterization method in multiple cancer types. One limitation for robust and reproducible analysis lies in the inter-reader variability of the tumor annotations, which can potentially cause differences in the extracted feature sets and results. In this study, the diagnostic potential of a rapid and clinically feasible VOI (Volume of Interest)-based approach to radiomics is investigated to assess MR-derived parameters for predicting molecular subtype, hormonal receptor status, Ki67- and HER2-Expression, metastasis of lymph nodes and lymph vessel involvement as well as grading in patients with breast cancer.A total of 98 treatment-naïve patients (mean 59.7 years, range 28.0-89.4) with BI-RADS 5 and 6 lesions who underwent a dedicated breast MRI prior to therapy were retrospectively included in this study. The imaging protocol comprised dynamic contrast-enhanced T1-weighted imaging and T2-weighted imaging. Tumor annotations were obtained by drawing VOIs around the primary tumor lesions followed by thresholding. From each segmentation, 13.118 quantitative imaging features were extracted and analyzed with machine learning methods. Validation was performed by 5-fold cross-validation with 25 repeats.METHODSA total of 98 treatment-naïve patients (mean 59.7 years, range 28.0-89.4) with BI-RADS 5 and 6 lesions who underwent a dedicated breast MRI prior to therapy were retrospectively included in this study. The imaging protocol comprised dynamic contrast-enhanced T1-weighted imaging and T2-weighted imaging. Tumor annotations were obtained by drawing VOIs around the primary tumor lesions followed by thresholding. From each segmentation, 13.118 quantitative imaging features were extracted and analyzed with machine learning methods. Validation was performed by 5-fold cross-validation with 25 repeats.Predictions for molecular subtypes obtained AUCs of 0.75 (HER2-enriched), 0.73 (triple-negative), 0.65 (luminal A) and 0.69 (luminal B). Differentiating subtypes from one another was highest for HER2-enriched vs triple-negative (AUC 0.97), followed by luminal B vs triple-negative (0.86). Receptor status predictions for Estrogen Receptor (ER), Progesterone Receptor (PR) and Hormone receptor positivity yielded AUCs of 0.67, 0.69 and 0.69, while Ki67 and HER2 Expressions achieved 0.81 and 0.62. Involvement of the lymph vessels could be predicted with an AUC of 0.8, while lymph node metastasis yielded an AUC of 0.71. Models for grading performed similar with an AUC of 0.71 for Elston-Ellis grading and 0.74 for the histological grading.RESULTSPredictions for molecular subtypes obtained AUCs of 0.75 (HER2-enriched), 0.73 (triple-negative), 0.65 (luminal A) and 0.69 (luminal B). Differentiating subtypes from one another was highest for HER2-enriched vs triple-negative (AUC 0.97), followed by luminal B vs triple-negative (0.86). Receptor status predictions for Estrogen Receptor (ER), Progesterone Receptor (PR) and Hormone receptor positivity yielded AUCs of 0.67, 0.69 and 0.69, while Ki67 and HER2 Expressions achieved 0.81 and 0.62. Involvement of the lymph vessels could be predicted with an AUC of 0.8, while lymph node metastasis yielded an AUC of 0.71. Models for grading performed similar with an AUC of 0.71 for Elston-Ellis grading and 0.74 for the histological grading.Our preliminary results of a rapid approach to VOI-based tumor-annotations for radiomics provides comparable results to current publications with the perks of clinical suitability, enabling a comprehensive non-invasive platform for breast tumor decoding and phenotyping.CONCLUSIONOur preliminary results of a rapid approach to VOI-based tumor-annotations for radiomics provides comparable results to current publications with the perks of clinical suitability, enabling a comprehensive non-invasive platform for breast tumor decoding and phenotyping. |
| Audience | Academic |
| Author | Umutlu, Lale Demircioglu, Aydin Nensa, Felix Forsting, Michael Pinker-Domenig, Katja Ingenwerth, Marc Morris, Elizabeth Hoffmann, Oliver Haubold, Johannes Grueneisen, Johannes |
| AuthorAffiliation | 1 Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany 2 Department of Pathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany 3 Department of Gynaecology and Obstetrics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany 4 Breast Imaging Service, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America Medical University of Vienna, AUSTRIA |
| AuthorAffiliation_xml | – name: 4 Breast Imaging Service, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America – name: 1 Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany – name: 3 Department of Gynaecology and Obstetrics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany – name: Medical University of Vienna, AUSTRIA – name: 2 Department of Pathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany |
| Author_xml | – sequence: 1 givenname: Aydin orcidid: 0000-0003-0349-5590 surname: Demircioglu fullname: Demircioglu, Aydin – sequence: 2 givenname: Johannes surname: Grueneisen fullname: Grueneisen, Johannes – sequence: 3 givenname: Marc surname: Ingenwerth fullname: Ingenwerth, Marc – sequence: 4 givenname: Oliver surname: Hoffmann fullname: Hoffmann, Oliver – sequence: 5 givenname: Katja orcidid: 0000-0002-2722-7331 surname: Pinker-Domenig fullname: Pinker-Domenig, Katja – sequence: 6 givenname: Elizabeth surname: Morris fullname: Morris, Elizabeth – sequence: 7 givenname: Johannes surname: Haubold fullname: Haubold, Johannes – sequence: 8 givenname: Michael surname: Forsting fullname: Forsting, Michael – sequence: 9 givenname: Felix orcidid: 0000-0002-5811-7100 surname: Nensa fullname: Nensa, Felix – sequence: 10 givenname: Lale surname: Umutlu fullname: Umutlu, Lale |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32589681$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNk1trFDEYhgep2IP-A9EBQfRi1yRzyMQLoRQPC5VCPdyGTPJlN2U2mSaZ6l76z810t3W3FCwDc_jyvG--Q-Yw27POQpY9x2iKC4rfXbjBW9FN-xSeIlKUDcWPsgPMCjKpCSr2tt73s8MQLhCqiqaun2T7BakaVjf4IPtznHvRG5VfuW5YQu50bmwEDyFOWhFA5aLvvRNyMS55oYxbGhlykbZeBRPGaOtBhJh_PZ_l2vk8Dst0VyCdMnaeSJX3C7Aurvrx-59ACivBP80ea9EFeLZ5HmU_Pn38fvJlcnr2eXZyfDqRtGriRBOiq7JmElUCANoagSoEpapWLdMaq4oVCnDLgALGdSUFaNCsBtJoVLC2OMpern37zgW-6V7gpMSUpmaQJhGzNaGcuOC9N0vhV9wJw68Dzs-58NHIDpJKlrgqKWUVLZlULSqwolq2tMWKNCh5VWuvwfZi9Ut03a0hRnwc4E0KfBwg3www6T5sshzaJSgJNnrR7SSzu2LNgs_dFacFZjUaDd5sDLy7HNIY-dIECV0nLLjhut4GkxIxktBXd9D7u7Kh5iIVbqx2aV85mvLjmlBalqwsEjW9h0qXgnReUoXapPiO4O2OIDERfse5GELgs2_nD2fPfu6yr7fYBYguLkI629E4G3bBF9udvm3xzb-RgPdrQHoXggfNpYli9Emlme5_cyzviB80_r_Scjin |
| CitedBy_id | crossref_primary_10_1007_s12149_021_01688_3 crossref_primary_10_1177_03000605241237867 crossref_primary_10_1259_bjro_20220002 crossref_primary_10_2217_fon_2022_0593 crossref_primary_10_1097_RLI_0000000000001010 crossref_primary_10_1007_s00330_024_10638_2 crossref_primary_10_1016_j_acra_2023_10_010 crossref_primary_10_3390_diagnostics10090708 crossref_primary_10_1186_s12880_021_00610_7 crossref_primary_10_3390_cancers14163905 crossref_primary_10_1007_s11547_021_01423_y crossref_primary_10_1186_s13244_021_01034_1 crossref_primary_10_3390_cancers13122928 crossref_primary_10_1097_RLI_0000000000000855 crossref_primary_10_3390_jcm12041372 crossref_primary_10_1155_2022_1955512 crossref_primary_10_3390_diagnostics12102558 crossref_primary_10_1002_imo2_19 crossref_primary_10_1016_j_crad_2022_04_015 crossref_primary_10_1038_s41598_024_62585_z crossref_primary_10_1097_MD_0000000000035830 crossref_primary_10_3390_cancers14071727 crossref_primary_10_1016_j_acra_2024_03_002 crossref_primary_10_1016_j_ejrad_2021_109996 crossref_primary_10_2174_1573405617666210303102526 crossref_primary_10_6009_jjrt_2021_JSRT_77_8_866 crossref_primary_10_1007_s11547_023_01718_2 crossref_primary_10_1007_s12094_023_03287_2 crossref_primary_10_3390_cancers16203480 crossref_primary_10_4236_ojapps_2021_119074 crossref_primary_10_1016_j_acra_2023_12_012 crossref_primary_10_1093_bjrai_ubae016 crossref_primary_10_1002_jmrs_709 crossref_primary_10_1088_1361_6560_ac7d8f crossref_primary_10_3390_curroncol28040217 crossref_primary_10_3390_jpm13071150 crossref_primary_10_1016_j_jrras_2024_101260 crossref_primary_10_1016_j_compbiomed_2022_106147 crossref_primary_10_1186_s13244_022_01170_2 crossref_primary_10_1186_s13244_022_01328_y crossref_primary_10_1007_s40846_024_00900_9 crossref_primary_10_1007_s10549_025_07614_9 |
| Cites_doi | 10.1007/978-1-4614-7657-3_19 10.3109/02841851.2010.498444 10.1118/1.4923882 10.1016/j.ejrad.2015.07.012 10.1016/j.canlet.2017.06.004 10.1007/s00261-018-1660-7 10.1016/j.acra.2008.06.005 10.1001/jama.295.21.2492 10.2214/AJR.18.20218 10.1148/radiol.14132641 10.1038/s41598-020-60393-9 10.1117/1.JMI.2.4.041007 10.1159/000351193 10.1088/0031-9155/61/13/R150 10.1007/s00261-019-02028-w 10.1371/journal.pone.0118261 10.1007/s00330-010-1722-x 10.1634/theoncologist.2011-S1-20 10.1002/mp.12925 10.1016/j.radonc.2016.04.004 10.1172/JCI33295 10.1016/j.acra.2005.08.035 10.1111/j.1365-2559.1991.tb00229.x 10.1158/0008-5472.CAN-17-0339 10.3389/fonc.2015.00272 10.1148/radiol.14131375 10.1002/mrm.22800 10.1148/radiol.14131332 10.1002/jmri.25870 10.1186/s13058-019-1187-z 10.20892/j.issn.2095-3941.2016.0066 10.1016/j.ejca.2011.11.036 10.1038/s41416-018-0185-8 10.1002/jmri.22268 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2020 Public Library of Science 2020 Demircioglu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2020 Demircioglu et al 2020 Demircioglu et al |
| Copyright_xml | – notice: COPYRIGHT 2020 Public Library of Science – notice: 2020 Demircioglu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2020 Demircioglu et al 2020 Demircioglu et al |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM ADTOC UNPAY DOA |
| DOI | 10.1371/journal.pone.0234871 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts ProQuest Nursing and Allied Health Journals - PSU access expires 11/30/25. Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni Edition) ProQuest One Sustainability (subscription) ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Database ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection ProQuest Biological Science Collection Agricultural Science Database Health & Medical Collection (Alumni Edition) Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database (subscription) ProQuest Nursing and Allied Health Premium AAdvanced Technologies & Aerospace Database (subscription) ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database (subscripiton) Materials Science Collection ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Agricultural Science Database MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository – sequence: 5 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) |
| DocumentTitleAlternate | A rapid VOI-based approach of radiomics analysis of breast MRI for tumor decoding of breast cancer |
| EISSN | 1932-6203 |
| ExternalDocumentID | 2417789628 oai_doaj_org_article_24c41547795749cdb031d7fcb7b1d280 oai:escholarship.org:ark:/13030/qt0r7091nc PMC7319601 A627744943 32589681 10_1371_journal_pone_0234871 |
| Genre | Validation Study Journal Article |
| GeographicLocations | Germany New York United States--US |
| GeographicLocations_xml | – name: Germany – name: New York – name: United States--US |
| GrantInformation_xml | – fundername: NCI NIH HHS grantid: P30 CA008748 |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESTFP ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PTHSS PUEGO PV9 PYCSY RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM ADRAZ ALIPV CGR CUY CVF ECM EIF IPNFZ NPM RIG BBORY 3V. 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PKEHL PQEST PQUKI PRINS RC3 7X8 5PM ADTOC UNPAY AAPBV ABPTK |
| ID | FETCH-LOGICAL-c758t-f22f5469c05aeeeb60ed3a77d6db9ff1d593de1b9e7e1165caefef96e28f039b3 |
| IEDL.DBID | UNPAY |
| ISSN | 1932-6203 |
| IngestDate | Sun Oct 01 00:11:26 EDT 2023 Fri Oct 03 12:50:39 EDT 2025 Sun Oct 26 04:14:23 EDT 2025 Tue Sep 30 16:33:09 EDT 2025 Wed Oct 01 14:43:02 EDT 2025 Tue Oct 07 07:40:27 EDT 2025 Mon Oct 20 21:45:02 EDT 2025 Mon Oct 20 16:15:50 EDT 2025 Thu Oct 16 14:47:49 EDT 2025 Thu Oct 16 14:06:53 EDT 2025 Thu May 22 20:33:47 EDT 2025 Mon Jul 21 05:33:01 EDT 2025 Thu Apr 24 22:56:12 EDT 2025 Wed Oct 01 04:29:37 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Language | English |
| License | This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. cc-by Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c758t-f22f5469c05aeeeb60ed3a77d6db9ff1d593de1b9e7e1165caefef96e28f039b3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 Competing Interests: The authors have declared that no competing interests exist. |
| ORCID | 0000-0003-0349-5590 0000-0002-5811-7100 0000-0002-2722-7331 |
| OpenAccessLink | https://proxy.k.utb.cz/login?url=https://escholarship.org/uc/item/0r7091nc |
| PMID | 32589681 |
| PQID | 2417789628 |
| PQPubID | 1436336 |
| PageCount | e0234871 |
| ParticipantIDs | plos_journals_2417789628 doaj_primary_oai_doaj_org_article_24c41547795749cdb031d7fcb7b1d280 unpaywall_primary_10_1371_journal_pone_0234871 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7319601 proquest_miscellaneous_2418124092 proquest_journals_2417789628 gale_infotracmisc_A627744943 gale_infotracacademiconefile_A627744943 gale_incontextgauss_ISR_A627744943 gale_incontextgauss_IOV_A627744943 gale_healthsolutions_A627744943 pubmed_primary_32589681 crossref_citationtrail_10_1371_journal_pone_0234871 crossref_primary_10_1371_journal_pone_0234871 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2020-06-26 |
| PublicationDateYYYYMMDD | 2020-06-26 |
| PublicationDate_xml | – month: 06 year: 2020 text: 2020-06-26 day: 26 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
| PublicationTitle | PloS one |
| PublicationTitleAlternate | PLoS One |
| PublicationYear | 2020 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | N Harbeck (pone.0234871.ref018) 2013; 8 PAT Baltzer (pone.0234871.ref030) 2010; 20 N Bhooshan (pone.0234871.ref037) 2011; 66 ME Mayerhoefer (pone.0234871.ref017) 2010; 32 JDC Hon (pone.0234871.ref019); 6 TP Coroller (pone.0234871.ref002) 2016; 119 M Dietzel (pone.0234871.ref031) 2010; 51 CW Elston (pone.0234871.ref022) 1991; 19 HJWL Aerts (pone.0234871.ref005) 2014; 5 A Saha (pone.0234871.ref009) 2018; 119 JJM van Griethuysen (pone.0234871.ref024) 2017; 77 Z Bodalal (pone.0234871.ref003) 2019; 44 J Haubold (pone.0234871.ref008) 2019 CP Smith (pone.0234871.ref006) 2019; 44 W Guo (pone.0234871.ref010) 2015; 2 M Dietzel (pone.0234871.ref034) 2020; 10 R Kikinis (pone.0234871.ref023) 2014 SSF Yip (pone.0234871.ref027) 2016; 61 MA Mazurowski (pone.0234871.ref012) 2015; 84 K. Polyak (pone.0234871.ref025) 2007; 117 NA Soliman (pone.0234871.ref033) 2016; 13 LA Carey (pone.0234871.ref020) 2006; 295 E Lotan (pone.0234871.ref007) 2019; 212 AB Ashraf (pone.0234871.ref016) 2014; 272 N Maforo (pone.0234871.ref032) 2015; 42 B Zhang (pone.0234871.ref035) 2017; 403 D Leithner (pone.0234871.ref029) 2019; 21 W Chen (pone.0234871.ref013) 2006; 13 K Pinker (pone.0234871.ref004) 2018; 47 P Lambin (pone.0234871.ref001) 2012; 48 O Grove (pone.0234871.ref028) 2015; 10 N Cho (pone.0234871.ref015) 2014; 272 MA Mazurowski (pone.0234871.ref021) 2014; 273 EA Perez (pone.0234871.ref026) 2011; 16 C Parmar (pone.0234871.ref036) 2015; 5 A Saha (pone.0234871.ref011) 2018; 45 K Nie (pone.0234871.ref014) 2008; 15 |
| References_xml | – volume: 6 start-page: 1864 ident: pone.0234871.ref019 article-title: Breast cancer molecular subtypes: from TNBC to QNBC publication-title: Am J Cancer Res – start-page: 277 volume-title: Intraoperative Imaging and Image-Guided Therapy year: 2014 ident: pone.0234871.ref023 doi: 10.1007/978-1-4614-7657-3_19 – volume: 51 start-page: 851 year: 2010 ident: pone.0234871.ref031 article-title: Application of artificial neural networks for the prediction of lymph node metastases to the ipsilateral axilla–initial experience in 194 patients using magnetic resonance mammography publication-title: Acta Radiol doi: 10.3109/02841851.2010.498444 – volume: 42 start-page: 3213 year: 2015 ident: pone.0234871.ref032 article-title: SU-D-BRA-02: Radiomics of Multi-Parametric Breast MRI in Breast Cancer Diagnosis: A Quantitative Investigation of Diffusion Weighted Imaging, Dynamic Contrast-Enhanced, and T2-Weighted Magnetic Resonance Imaging publication-title: Medical Physics doi: 10.1118/1.4923882 – volume: 84 start-page: 2117 year: 2015 ident: pone.0234871.ref012 article-title: Recurrence-free survival in breast cancer is associated with MRI tumor enhancement dynamics quantified using computer algorithms publication-title: European Journal of Radiology doi: 10.1016/j.ejrad.2015.07.012 – volume: 403 start-page: 21 year: 2017 ident: pone.0234871.ref035 article-title: Radiomic machine-learning classifiers for prognostic biomarkers of advanced nasopharyngeal carcinoma publication-title: Cancer Letters doi: 10.1016/j.canlet.2017.06.004 – volume: 44 start-page: 2021 year: 2019 ident: pone.0234871.ref006 article-title: Radiomics and radiogenomics of prostate cancer publication-title: Abdom Radiol doi: 10.1007/s00261-018-1660-7 – volume: 15 start-page: 1513 year: 2008 ident: pone.0234871.ref014 article-title: Quantitative Analysis of Lesion Morphology and Texture Features for Diagnostic Prediction in Breast MRI publication-title: Academic Radiology doi: 10.1016/j.acra.2008.06.005 – volume: 295 start-page: 2492 year: 2006 ident: pone.0234871.ref020 article-title: Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study publication-title: JAMA doi: 10.1001/jama.295.21.2492 – volume: 212 start-page: 26 year: 2019 ident: pone.0234871.ref007 article-title: State of the Art: Machine Learning Applications in Glioma Imaging publication-title: American Journal of Roentgenology doi: 10.2214/AJR.18.20218 – volume: 273 start-page: 365 year: 2014 ident: pone.0234871.ref021 article-title: Radiogenomic Analysis of Breast Cancer: Luminal B Molecular Subtype Is Associated with Enhancement Dynamics at MR Imaging publication-title: Radiology doi: 10.1148/radiol.14132641 – volume: 10 start-page: 3664 year: 2020 ident: pone.0234871.ref034 article-title: Automated volumetric radiomic analysis of breast cancer vascularization improves survival prediction in primary breast cancer publication-title: Sci Rep doi: 10.1038/s41598-020-60393-9 – volume: 2 start-page: 041007 year: 2015 ident: pone.0234871.ref010 article-title: Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics data publication-title: J Med Imag doi: 10.1117/1.JMI.2.4.041007 – volume: 8 start-page: 102 year: 2013 ident: pone.0234871.ref018 article-title: St. Gallen 2013: Brief Preliminary Summary of the Consensus Discussion publication-title: Breast Care doi: 10.1159/000351193 – volume: 61 start-page: R150 year: 2016 ident: pone.0234871.ref027 article-title: Applications and limitations of radiomics publication-title: Phys Med Biol doi: 10.1088/0031-9155/61/13/R150 – volume: 44 start-page: 1960 year: 2019 ident: pone.0234871.ref003 article-title: Radiogenomics: bridging imaging and genomics publication-title: Abdom Radiol doi: 10.1007/s00261-019-02028-w – volume: 10 year: 2015 ident: pone.0234871.ref028 article-title: Quantitative Computed Tomographic Descriptors Associate Tumor Shape Complexity and Intratumor Heterogeneity with Prognosis in Lung Adenocarcinoma publication-title: PLoS One doi: 10.1371/journal.pone.0118261 – year: 2019 ident: pone.0234871.ref008 article-title: Non-invasive tumor decoding and phenotyping of cerebral gliomas utilizing multiparametric 18F-FET PET-MRI and MR Fingerprinting publication-title: Eur J Nucl Med Mol Imaging – volume: 20 start-page: 1563 year: 2010 ident: pone.0234871.ref030 article-title: Computer-aided interpretation of dynamic magnetic resonance imaging reflects histopathology of invasive breast cancer publication-title: Eur Radiol doi: 10.1007/s00330-010-1722-x – volume: 16 start-page: 20 year: 2011 ident: pone.0234871.ref026 article-title: Breast Cancer Management: Opportunities and Barriers to an Individualized Approach publication-title: The Oncologist doi: 10.1634/theoncologist.2011-S1-20 – volume: 45 start-page: 3076 year: 2018 ident: pone.0234871.ref011 article-title: Breast cancer MRI radiomics: An overview of algorithmic features and impact of inter-reader variability in annotating tumors publication-title: Med Phys doi: 10.1002/mp.12925 – volume: 119 start-page: 480 year: 2016 ident: pone.0234871.ref002 article-title: Radiomic phenotype features predict pathological response in non-small cell lung cancer publication-title: Radiotherapy and Oncology doi: 10.1016/j.radonc.2016.04.004 – volume: 117 start-page: 3155 year: 2007 ident: pone.0234871.ref025 article-title: Breast cancer: origins and evolution publication-title: J Clin Invest doi: 10.1172/JCI33295 – volume: 13 start-page: 63 year: 2006 ident: pone.0234871.ref013 article-title: A Fuzzy C-Means (FCM)-Based Approach for Computerized Segmentation of Breast Lesions in Dynamic Contrast-Enhanced MR Images1 publication-title: Academic Radiology doi: 10.1016/j.acra.2005.08.035 – volume: 19 start-page: 403 year: 1991 ident: pone.0234871.ref022 article-title: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up publication-title: Histopathology doi: 10.1111/j.1365-2559.1991.tb00229.x – volume: 77 start-page: e104 year: 2017 ident: pone.0234871.ref024 article-title: Computational Radiomics System to Decode the Radiographic Phenotype publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-17-0339 – volume: 5 year: 2015 ident: pone.0234871.ref036 article-title: Aerts HJWL. Radiomic Machine-Learning Classifiers for Prognostic Biomarkers of Head and Neck Cancer publication-title: Front Oncol doi: 10.3389/fonc.2015.00272 – volume: 272 start-page: 374 year: 2014 ident: pone.0234871.ref016 article-title: Identification of Intrinsic Imaging Phenotypes for Breast Cancer Tumors: Preliminary Associations with Gene Expression Profiles publication-title: Radiology doi: 10.1148/radiol.14131375 – volume: 66 start-page: 555 year: 2011 ident: pone.0234871.ref037 article-title: Combined use of T2-weighted MRI and T1-weighted dynamic contrast–enhanced MRI in the automated analysis of breast lesions publication-title: Magnetic Resonance in Medicine doi: 10.1002/mrm.22800 – volume: 272 start-page: 385 year: 2014 ident: pone.0234871.ref015 article-title: Breast Cancer: Early Prediction of Response to Neoadjuvant Chemotherapy Using Parametric Response Maps for MR Imaging publication-title: Radiology doi: 10.1148/radiol.14131332 – volume: 47 start-page: 604 year: 2018 ident: pone.0234871.ref004 article-title: Background, Current Role and Potential Applications of Radiogenomics publication-title: J Magn Reson Imaging doi: 10.1002/jmri.25870 – volume: 5 year: 2014 ident: pone.0234871.ref005 article-title: Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach publication-title: Nature Communications – volume: 21 start-page: 106 year: 2019 ident: pone.0234871.ref029 article-title: Radiomic signatures with contrast-enhanced magnetic resonance imaging for the assessment of breast cancer receptor status and molecular subtypes: initial results publication-title: Breast Cancer Res doi: 10.1186/s13058-019-1187-z – volume: 13 start-page: 496 year: 2016 ident: pone.0234871.ref033 article-title: Ki-67 as a prognostic marker according to breast cancer molecular subtype publication-title: Cancer Biol Med doi: 10.20892/j.issn.2095-3941.2016.0066 – volume: 48 start-page: 441 year: 2012 ident: pone.0234871.ref001 article-title: Radiomics: Extracting more information from medical images using advanced feature analysis publication-title: European Journal of Cancer doi: 10.1016/j.ejca.2011.11.036 – volume: 119 start-page: 508 year: 2018 ident: pone.0234871.ref009 article-title: A machine learning approach to radiogenomics of breast cancer: a study of 922 subjects and 529 DCE-MRI features publication-title: Br J Cancer doi: 10.1038/s41416-018-0185-8 – volume: 32 start-page: 352 year: 2010 ident: pone.0234871.ref017 article-title: Texture-based classification of focal liver lesions on MRI at 3.0 Tesla: A feasibility study in cysts and hemangiomas publication-title: Journal of Magnetic Resonance Imaging doi: 10.1002/jmri.22268 |
| SSID | ssj0053866 |
| Score | 2.5047965 |
| Snippet | Recently, radiomics has emerged as a non-invasive, imaging-based tissue characterization method in multiple cancer types. One limitation for robust and... Background Recently, radiomics has emerged as a non-invasive, imaging-based tissue characterization method in multiple cancer types. One limitation for robust... BackgroundRecently, radiomics has emerged as a non-invasive, imaging-based tissue characterization method in multiple cancer types. One limitation for robust... Background Recently, radiomics has emerged as a non-invasive, imaging-based tissue characterization method in multiple cancer types. One limitation for robust... |
| SourceID | plos doaj unpaywall pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e0234871 |
| SubjectTerms | Adult Aged Aged, 80 and over Analysis Annotations Biology and Life Sciences Biomarkers, Tumor - metabolism Breast - diagnostic imaging Breast - pathology Breast cancer Breast Neoplasms - diagnosis Breast Neoplasms - pathology Computer and Information Sciences Computer assisted image interpretation Diagnosis Diagnostic systems ErbB-2 protein Estrogen receptors Estrogens Feature extraction Female Health aspects Humans Image Interpretation, Computer-Assisted - methods Image segmentation Learning algorithms Lesions Lymph nodes Lymphatic system Machine Learning Magnetic resonance imaging Magnetic Resonance Imaging - methods Medical imaging Medicine and Health Sciences Metastases Metastasis Middle Aged Neoplasm Grading Patients Phenotyping Progesterone Radiomics Receptors Research and Analysis Methods Retrospective Studies Studies Time Factors Tumors Vessels |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Nb9MwFLdQL3BBjK8VBhiEBBzSJXZix8eCmDakgTQY2i2yYxsqlaRqUqEd-c95L3GjRkzaDlxyiJ8j-X2_9r2fCXmd8tSXnhsoSzSPUid0pFJM5DiLuRUus90c9-lncXyefrrILnau-sKesB4euGfcIUtLiDGplCqTqSqtAS200pdGmsSyvKvW41xti6neB4MVCxEG5bhMDoNcZqu6cjOIUpClJ6NA1OH1D155slrWzVUp57-dk7c31Upf_tbL5U5YOrpH7oZ8ks77c-yRW666T_aCxTb0bYCVfveA_JnTtV4tLO0dEq09RawIvJsjwlhm6RZfHJfW2i5wYLmhOsCW4FuDLewtPT07oZDs0nbzC54WKliMgEBpKbaM1e0lTmHtbChRt9YPyfnRx28fjqNwAUNUQhnRRp4xn0H9XMaZds4ZETvLtZR4CZXyPrGZ4tYlRjnpEMan1M47r4RjuY-5MvwRmVTA8n1CldBg_BkILcbZusRI8MUWsjnnjXVGTgnfSqMoAzo5XpKxLLq_3CRUKT1DC5RhEWQ4JdGwa9Wjc1xD_x4FPdAitnb3AjSuCBpXXKdxU_IC1aToB1UHD1HMBYNcOlUpn5JXHQXia1TYwPNDb5qmOPny_QZEX89GRG8Cka-BHaUOQxNwJsTtGlEejCjBS5Sj5X1U6i1XGjhlImWuBMth51bRr15-OSzjR7Epr3L1pqPB9DBWbEoe93YxcJazDHbnwHE5spgR68cr1eJnB28uMSrEsHM22NaNhPvkfwj3KbnD8BeVWERMHJBJu964Z5B2tuZ552H-AhBkgcc priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELdG9wAviPG1wgCDkICHdKmdxPUDQh3atCGtoMLQ3iI7tsekkoSmFdoj_zl3iRMWMcFe-hCfo-bO95Xc_Y6QlxGPXOa4hrRE8SCyiQpkhIEcZyE3iY1N3cd9PEsOT6IPp_HpBpm1vTBYVtnaxNpQmyLDd-S74GmEmMiETd6VPwKcGoVfV9sRGsqPVjBva4ixG2STITLWgGzu7c8-zVvbDNqdJL6BjovxrpfXqCxyOwLvBdH7uOegahz_zloPykVRXRWK_l1ReXOdl-rip1osLrmrgzvkto8z6bQ5GFtkw-Z3yZbX5Iq-9nDTb-6RX1O6VOW5oY2hooWjiCGBMzsC9HGGtrjjuLRU5hwbmSuqPJwJXtVY2r6ix_MjCkEwXa2_w6-BzBY9I1AaiqVkxeoCu7MubcjwzC3vk5OD_S_vDwM_mCHIIL1YBY4xF0NenYWxstbqJLSGKyFwOJV0bmxiyY0da2mFRXifTFlnnUwsm7iQS80fkEEOLN8mVCYKjEIsNM4MBhlrATbaQJRnnTZWiyHhrTTSzKOW4_CMRVp_ihOQvTQMTVGGqZfhkATdrrJB7fgP_R4KuqNFzO36QrE8S70KpyzKINqJhJCxiGRmNNhDI1ym4c8bNgmH5Bkek7RpYO0sRzpNGMTYkYz4kLyoKRB3I8fCnjO1rqr06OPXaxB9nveIXnkiVwA7MuWbKeCZEM-rR7nTowTrkfWWt_FQt1yp0j96Bjvbg3718vNuGW-KxXq5LdY1DYaNoWRD8rDRi46znMWwewIcFz2N6bG-v5Kff6thzwV6ixB2jjrdupZwH_37OR6TWwzfoYRJwJIdMlgt1_YJBJor_dRbj9-c3ICI priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELem8gAviPG1wgCDkICHVKmdxPUDQgUxbUgFaVC0t8iO7a1SSUqSCvrIf85d4kaLKNpe-hDfRcmd7-53je-OkJcRj1zmuIa0RPEgsokKZIRAjrOQm8TGpqnjnn1OjufRp7P4bI9sZ7Z6AVY7UzucJzUvl6PfPzfvwODfNlMbxHjLNFoVuR1BDAIMDvnQDYhVEoc5zKLuuwJYd_P1ElFLkMDT-GK6_92lF6yanv6d5x6slkW1C5b-e7ry5jpfqc0vtVxeCl1Hd8htjznptN0k-2TP5nfJvrfqir72raff3CN_prRUq4WhrdOihaPYTwLndwQY7wzd9iDHpVKZBRY1V1T51iZ4VeMx95rOTk8oAGJar3_Ar4EsF6MkUBqKx8qKeoOVWpcYMtx_5X0yP_r47cNx4Ic0BBmkGnXgGHMx5NhZGCtrrU5Ca7gSAgdVSefGJpbc2LGWVlhs9ZMp66yTiWUTF3Kp-QMyyEHkB4TKRIGDiIXG-cGALLQAf20A8VmnjdViSPhWG2nmO5jjII1l2nyWE5DJtAJNUYep1-GQBB3Xqu3gcQX9e1R0R4v9t5sLRXmeenNOWZQB8omEkLGIZGY0-EYjXKbh4Q2bhEPyDLdJ2hazdl4knSYM8HYkIz4kLxoK7MGR4yGfc7WuqvTky_drEH097RG98kSuAHFkyhdWwDthb68e5WGPEjxJ1ls-wE29lUoFbzkWYiITNgHO7Ubfvfy8W8ab4sG93BbrhgYhZCjZkDxs7aKTLGcxcE9A4qJnMT3R91fyxUXTAl1g5AiBc9TZ1rWU--hKvTwmtxj-pRImAUsOyaAu1_YJ4M5aP21cyV8854K3 priority: 102 providerName: Scholars Portal |
| Title | A rapid volume of interest-based approach of radiomics analysis of breast MRI for tumor decoding and phenotyping of breast cancer |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/32589681 https://www.proquest.com/docview/2417789628 https://www.proquest.com/docview/2418124092 https://pubmed.ncbi.nlm.nih.gov/PMC7319601 https://escholarship.org/uc/item/0r7091nc https://doaj.org/article/24c41547795749cdb031d7fcb7b1d280 http://dx.doi.org/10.1371/journal.pone.0234871 |
| UnpaywallVersion | submittedVersion |
| Volume | 15 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVFSB databaseName: Free Full-Text Journals in Chemistry customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: HH5 dateStart: 20060101 isFulltext: true titleUrlDefault: http://abc-chemistry.org/ providerName: ABC ChemistRy – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: KQ8 dateStart: 20060101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: KQ8 dateStart: 20061001 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: DOA dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1932-6203 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: ABDBF dateStart: 20080101 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVEBS databaseName: EBSCOhost Food Science Source customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: A8Z dateStart: 20080101 isFulltext: true titleUrlDefault: https://search.ebscohost.com/login.aspx?authtype=ip,uid&profile=ehost&defaultdb=fsr providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: DIK dateStart: 20060101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: GX1 dateStart: 20060101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M~E dateStart: 20060101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: RPM dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: 7X7 dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1932-6203 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: BENPR dateStart: 20061201 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Technology Collection customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: 8FG dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/technologycollection1 providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: 8C1 dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal - Open Access customDbUrl: eissn: 1932-6203 dateEnd: 20250930 omitProxy: true ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M48 dateStart: 20061201 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELbo7gEuQHl1oSwGIQGHbLPOw8lxW7W0SC1Voag9RX7SFUt2tUmEyo1_zkzijRqoRLn4EM9EsT0vxzOfCXkdBqFVNpCwLRGBF5pYeGmIgVzA_EDHJtJ1HffhUbx_Gn44i84cWDTWwpjVnu5iuqgP8qvmTrItf8nBteVqjfTjCMLuHumfHh1PzptTY-bF8G5XGhfw8ZZbidFinpsR-CWIy8cd11Mj9Ld2uLeYzYvrgsy_cyVvV_lCXP4Qs9kVR7R3r0nhKmr8Qsw_-TaqSjlSP_9Ad7zRGO-Tuy4cpZNGftbJLZM_IOtO4Qv61qFSv3tIfk3oUiymmjb2jM4tRagJvNrDQ1eo6QqeHLuWQk-x3rmgwqGe4FOJGfAlPTw5oBAr07L6Dq2GDTA6UKDUFDPO5uUlFnFdYVAomstH5HRv9_POvufub_AU7EJKzzJmI9h-Kz8SxhgZ-0YHgnO8wyq1dqyjNNBmLFPDDaIAKWGssWlsWGL9IJXBY9LLYf02CE1jAbYj4hKvFoagQ3Iw5RqCQWOlNpIPSLBa2kw5cHO8Y2OW1Sd2HDY5zYRmKBCZE4gB8VquRQPu8Q_6bZSalhahuesHsIiZ0_SMhQqCopDzNOJhqrQEs6m5VRI-XrPEH5AXKHNZU-faGphsEjMIxcM0DAbkVU2B8Bw55v98FVVRZAcfv9yA6NNJh-iNI7JzmA4lXM0FjAlhvzqUmx1KMDKq072BGrKalQJGOeY8SWOWAOdKa67vftl240sxpy8386qmwejST9mAPGmUrJ3ZgEXAncCM8476daa-25NPL2p0dI5OxQfOUauoN1rcp__L8IzcYfjzxY89Fm-SXrmszHOIUEs5JGv8jEOb7Iyx3Xs_JP3t3aPjk2H9zwfawzAZOgv2G2iimtA |
| linkProvider | Unpaywall |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VcCgXRHk1UOiCQMDBqbNr78YHhMKjamhTpNKi3Mzau1siBdvEiaoc-UP8Rmb8ohYV9NJLDt5ZK56Z_WbGngchzzzu2djyCMISxR3PCOUEHjpynLlcC-Proo57fCj2TryPE3-yRn7VtTCYVlljYgHUOo3xHfkOWBopB4FggzfZDwenRuHX1XqERqkW-2Z1BiFb_nr0HuT7nLHdD8fv9pxqqoATg2-8cCxj1oegMHZ9ZYyJhGs0V1LiZKXA2r72A65NPwqMNNibJlbGGhsIwwbW5UHE4b7XyHWPA5bA-ZGTJsAD7BCiKs_jsr9TaUMvSxPTA9sIsUG_Zf6KKQGNLehkszS_yNH9O19zfZlkanWmZrNzxnD3FrlZebF0WKrdBlkzyW2yUeFETl9Wzaxf3SE_h3SusqmmJQzS1FLsUIETQRy0oJrWXc1xaa70FMukc6qqZil4NcLE-QUdH40ouNh0sfwOvxriZrS7QKkpJqqlixXWfp3bEKNGz--SkysR0D3SSYDlm4QGQgHk-DLCicSgQZEEC6DBhzQ20iaSXcJraYRx1RMdR3PMwuJDn4TYqGRoiDIMKxl2idPsysqeIP-hf4uCbmixo3dxIZ2fhhVAhMyLwZfypAx86QWxjgBttbRxBH9es4HbJduoJmFZHtvgUjgUDDx4L_B4lzwtKLCrR4JpQ6dqmefh6NOXSxB9PmoRvaiIbArsiFVVqgHPhN3CWpRbLUrApri1vIlKXXMlD_-cYthZK_rFy0-aZbwppgImJl0WNOiUugHrkvvluWg4y5kPuwfAcdk6MS3Wt1eS6beiqbpEW-TCzl5zti4l3Af_fo5tsr53PD4ID0aH-w_JDYZva1zhMLFFOov50jwCl3YRPS5whJKvVw1cvwGgt7l9 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkYALory6UKhBIOCQbdZO4vUBoUKpupQWVCjaW3Biu1RakrDZVbVH_ha_jpnECY2ooJde9hCPo83M-JuZZB6EPAl4YFPLEwhLFPcCEylPBujIceZzHZlQV3Xce_vRzmHwbhyOl8ivphYG0yobTKyAWucpviPfAEsjxFBGbLhhXVrEx63tV8UPDydI4ZfWZpxGrSK7ZnEC4Vv5crQFsn7K2Pbbz292PDdhwEvBT555ljEbQoCY-qEyxiSRbzRXQuCUJWntQIeSazNIpBEG-9SkylhjZWTY0PpcJhzue4lcFpxLTCcU4zbYAxyJIleqx8Vgw2lGv8gz0wc7CXHCoGMKq4kBrV1YLiZ5eZbT-3fu5tV5VqjFiZpMThnG7RvkuvNo6WatgitkyWQ3yYrDjJI-d42tX9wiPzfpVBXHmtaQSHNLsVsFTgfx0Jpq2nQ4x6Wp0sdYMl1S5Rqn4NUEk-hndO9gRMHdprP5d_jVEEOjDQZKTTFpLZ8tsA7s1IYUtXt6mxxeiIDukOUMWL5KqIwUwE8oEpxODNqUCLAGGvxJYxNtEtEjvJFGnLr-6DimYxJXH_0ExEk1Q2OUYexk2CNeu6uo-4P8h_41Crqlxe7e1YV8ehQ7sIhZkIJfFQghQxHIVCeAvFrYNIE_r9nQ75F1VJO4LpVtMSrejBh484EMeI88riiww0eGZ-VIzcsyHn34cg6iTwcdomeOyObAjlS5sg14Juwc1qFc61ACTqWd5VVU6oYrZfznRMPORtHPXn7ULuNNMS0wM_m8okEH1ZesR-7W56LlLGch7B4Cx0XnxHRY313Jjr9VDdYF2iUfdvbbs3Uu4d7793OskysAWfH70f7ufXKN4YsbP_JYtEaWZ9O5eQDe7Sx5WMEIJV8vGrd-A2cNvcA |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3Nb9MwFLegO8AFGF8rDDAICTikS-0kbo4FMW1IG2hQNE6RP1lFSaMmERo3_nPeS9xogUmUSw_xc1Tb7zN-7_cIeR7xyGnHFYQlkgeRTWSQRujIcRZyk9jYNHXcR8fJwSx6dxqferBorIWx65jubF40F_l125NsL1wJMG25vkq2khjc7gHZmh1_mH5pb41ZkMC7fWkcF-M9fxKjYpnbEdgl8MvHPdPTIPR3enhQLJblZU7m37mS1-q8kOc_5GJxwRDt32xTuMoGvxDzT76N6kqN9M8_0B03WuMtcsO7o3Ta8s82uWLz22TbC3xJX3pU6ld3yK8pXclibmirz-jSUYSawNYeAZpCQ9fw5Di0kmaO9c4llR71BJ8qzICv6NHJIQVfmVb1d_g1EACjAQVKQzHjbFmdYxHXhQkaWXN1l8z23356cxD4_g2BhiikChxjLobwW4extNaqJLSGSyGwh1Xq3NjEKTd2rFIrLKIAaWmddWli2cSFPFX8HhnkcH47hKaJBN0RC4WthcHpUAJUuQFn0DplrBJDwtdHm2kPbo49NhZZc2MnIMhpNzRDhsg8QwxJ0M0qWnCPf9C_Rq7paBGau3kAh5h5Sc9YpMEpioRIYxGl2ihQm0Y4reDPGzYJh-QJ8lzW1rl2CiabJgxc8SiN-JA8aygQniPH_J-vsi7L7PD95w2IPp70iF54IreE7dDS11zAmhD2q0e526MEJaN7wzsoIetdKWGVYyEmacImMHMtNZcPP-2G8aWY05fbZd3QoHcZpmxI7rdC1u0sZzHMnsCOi5749ba-P5LPzxp0dIFGJYSZo05QNzrcB_874SG5zvDjS5gELNklg2pV20fgoVbqsddNvwHzo5TN |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+rapid+volume+of+interest-based+approach+of+radiomics+analysis+of+breast+MRI+for+tumor+decoding+and+phenotyping+of+breast+cancer&rft.jtitle=PloS+one&rft.au=Nensa%2C+Felix&rft.au=Umutlu%2C+Lale&rft.au=Grueneisen%2C+Johannes&rft.au=Forsting%2C+Michael&rft.date=2020-06-26&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=15&rft.issue=6&rft.spage=e0234871&rft_id=info:doi/10.1371%2Fjournal.pone.0234871&rft.externalDBID=n%2Fa&rft.externalDocID=A627744943 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |